NCT00010439View on ClinicalTrials.gov

Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile Osteoporosis

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 30, 2000

Primary Completion Date

October 31, 2003

Study Completion Date

November 30, 2008

Conditions
Osteoporosis
Interventions
DRUG

Alendronate

Pill, 35mg or 70mg weekly, depending upon the body weight for 12 months.

Trial Locations (1)

29425

Medical University of South Carolina, Charleston

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Medical University of South Carolina

OTHER

NCT00010439 - Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile Osteoporosis | Biotech Hunter | Biotech Hunter